18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice

Autor: Anandharajan, Rathinasabapathy, Sayyed, Sufyan G., Doshi, Lalit S., Dixit, Pooja, Chandak, Prakash G., Dixit, Amol V., Brahma, Manoja K., Deshmukh, Nitin J., Gupte, Ravindra, Damre, Anagha, Suthar, Jaspreet, Padigaru, Muralidhara, Sharma, Somesh D., Nemmani, Kumar V.S.
Zdroj: In Metabolism 2009 58(10):1503-1516
Databáze: ScienceDirect